Home/Author

Christopher R. Flowers

13 works· latest 2021· 5 institutionscluster: provisionalORCID 0000-0002-9524-3990

h-index13

i1013

Citations881

Works here13

Most cited in this library

First- and Second-Line Bevacizumab in Addition to Chemotherapy for Metastatic Colorectal Cancer: A United States–Based Cost-Effectiveness Analysis2015 · 157 citations
Cost-Effectiveness of Immune Checkpoint Inhibition inBRAFWild-Type Advanced Melanoma2017 · 108 citations
Cost-Effectiveness Analysis of Regorafenib for Metastatic Colorectal Cancer2015 · 94 citations
Charting the future of cancer health disparities research: A position statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute2017 · 82 citations
Metastatic Colorectal Cancer: A Systematic Review of the Value of Current Therapies2015 · 82 citations

Works

13 shown

Influenza Vaccination Rates Among Patients With a History of Cancer: Analysis of the National Health Interview Survey

Open Forum Infectious Diseases·2021·4 authors·Open access

20citations

Microsimulation Modeling in Oncology

JCO Clinical Cancer Informatics·2018·6 authors·Open access

33citations

The importance of immunization in cancer prevention, treatment, and survivorship

CA A Cancer Journal for Clinicians·2017·5 authors·review·Open access

50citations

Charting the future of cancer health disparities research: A position statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute

CA A Cancer Journal for Clinicians·2017·14 authors·Open access

82citations

Charting the Future of Cancer Health Disparities Research: A Position Statement From the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute

Journal of Clinical Oncology·2017·14 authors

79citations

American Society of Clinical Oncology Strategic Plan for Increasing Racial and Ethnic Diversity in the Oncology Workforce

Journal of Clinical Oncology·2017·12 authors

53citations

Cost-Effectiveness of Immune Checkpoint Inhibition inBRAFWild-Type Advanced Melanoma

Journal of Clinical Oncology·2017·6 authors·Open access

108citations

Making the Case for Improving Oncology Workforce Diversity

American Society of Clinical Oncology Educational Book·2017·3 authors

31citations

Metastatic Colorectal Cancer: A Systematic Review of the Value of Current Therapies

Clinical Colorectal Cancer·2015·5 authors·review·Open access

82citations

Cost-Effectiveness Analysis of Regorafenib for Metastatic Colorectal Cancer

Journal of Clinical Oncology·2015·8 authors·Open access

94citations

First- and Second-Line Bevacizumab in Addition to Chemotherapy for Metastatic Colorectal Cancer: A United States–Based Cost-Effectiveness Analysis

Journal of Clinical Oncology·2015·7 authors·Open access

157citations

A black‐white comparison of the quality of stage‐specific colon cancer treatment

Cancer·2009·11 authors·Open access

24citations

Practical approach for using Medicare data to estimate costs for cost–effectiveness analysis

Expert Review of Pharmacoeconomics & Outcomes Research·2005·4 authors

68citations